info@hoththerapeutics.com Our Pipeline
  • Twitter
  • Instagram
Hoth Therapeutics
  • Twitter
  • Instagram
  • Home
  • About
    • About Hoth
    • A Letter From Our CEO
    • Our Team
    • Scientific Advisory Board
    • Careers
  • For Patients
    • For Patients
    • Expanded Access Program
    • Clinical Trials
    • Oncology
    • Neurology
    • Inflammatory
    • Dermatology
    • Devices
    • Pipeline
  • Partnering
    • University Collaborations
    • Partnering With Hoth
  • Investors/Media
  • Contact
Select Page

EA Logo

Recent Posts

  • HOTH THERAPEUTICS, INC. TO PRESENT AT THE THINKEQUITY CONFERENCE
  • Hoth Therapuetics Inc. Announces the Addition of Dr. Richard D Granstein, M.D. to the Company’s Technology Advisory Board
  • Hoth Therapuetics Inc. Announces the Addition of Dr. Andrew Herr to the Company’s Technology Advisory Board
  • SPHERIX INC. ANNOUNCES CLOSING OF THE DEAL WITH HOTH THERAPEUTICS
  • SPHERIX ISSUES LETTER TO SHAREHOLDERS

Helpful Links

  • Home
  • Investors
  • About Us
  • Our Team
  • Contact Us

Contact
(646) 756-2997
info@hoththerapeutics.com

About
Hoth Therapeutics

At Hoth Therapeutics, we strive to develop innovative, impactful, and ground-breaking treatments with a goal to improve patient quality of life. We are a catalyst in early-stage pharmaceutical research and development, elevating promising drugs from the bench to pre-clinical and clinical testing.

Contact
(646) 756-2997
info@hoththerapeutics.com

Follow Us


  • Twitter

  • Instagram
© 2022 Hoth Therapeutics. All Rights Reserved
Terms & ConditionsPrivacy PolicySite Map